Decoding 9 Analyst Evaluations For Axsome Therapeutics
Decoding 9 Analyst Evaluations For Axsome Therapeutics
解码关于axsome therapeutics的9位分析师评估
Axsome Therapeutics (NASDAQ:AXSM) has been analyzed by 9 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
在过去三个月中，Axsome Therapeutics（纳斯达克：AXSM）受到9名分析师的分析，展示了从看好到看淡的不同观点。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表总结了他们最近的评级，展示了过去30天内不断变化的情绪，并将其与前几个月进行了比较。
Analysts have set 12-month price targets for Axsome Therapeutics, revealing an average target of $129.89, a high estimate of $190.00, and a low estimate of $95.00. Surpassing the previous average price target of $127.11, the current average has increased by 2.19%.
分析师为Axsome Therapeutics设定了12个月的目标价，揭示了平均目标值为129.89美元，最高估值为190.00美元，最低估值为95.00美元。当前平均价值上涨了2.19％，超过了之前的平均目标价值127.11美元。
Interpreting Analyst Ratings: A Closer Look
解读分析师评级：更深入的了解
The standing of Axsome Therapeutics among financial experts becomes clear with a...
通过对最近分析师行动进行...
登录免费看全文
登录/注册